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Abstract
Cystic fibrosis (CF) is a debilitating chronic condition, which requires complex and expensive
disease management. Exercise has now been recognised as a critical factor in improving
health and quality of life in patients with CF. Hence, cardiopulmonary exercise testing
(CPET) is used to determine aerobic fitness of young patients as part of the clinical manage-
ment of CF. However, at present there is a lack of conclusive evidence for one limiting sys-
tem of aerobic fitness for CF patients at individual patient level. Here, we perform detailed
data analysis that allows us to identify important systems-level factors that affect aerobic fit-
ness. We use patients’ data and principal component analysis to confirm the dependence of
CPET performance on variables associated with ventilation and metabolic rates of oxygen
consumption. We find that the time at which participants cross the gas exchange threshold
(GET) is well correlated with their overall performance. Furthermore, we propose a predic-
tive modelling framework that captures the relationship between ventilatory dynamics, lung
capacity and function and performance in CPET within a group of children and adolescents
with CF. Specifically, we show that using Gaussian processes (GP) we can predict GET at
the individual patient level with reasonable accuracy given the small sample size of the avail-
able group of patients. We conclude by presenting an example and future perspectives for
improving and extending the proposed framework. The modelling and analysis have the
potential to pave the way to designing personalised exercise programmes that are tailored
to specific individual needs relative to patient’s treatment therapies.
Introduction
Cystic fibrosis (CF) is the most common life shortening genetic disease in the Caucasian popu-
lation, affecting nearly 11,000 individuals in the United Kingdom (UK) [1] and predominantly
manifests itself throughout the respiratory, digestive and reproductive systems of the human
body. The genetic mutation responsible for CF results in reduced trans-epithelial chloride
transport, and increased sodium and water absorption, thus reducing the hydration status of
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the mucosal lining of the airway and digestive systems. The resultant viscous mucus is liable to
increased infection and further inflammation and a progressive decline in lung function [2].
Currently there is no cure for CF and therefore CF is a diseased that is managed with appropri-
ate medication, nutrition, physiotherapy and exercise. Enhanced aerobic fitness as represented
by maximal oxygen consumption ( _VO2max) is associated with lower risk of hospitalisation,
increased exercise tolerance, reduced residual volume, increased endurance of the respiratory
muscles, enhanced sputum expectoration and decreased rate of decline in pulmonary function
[3–7]. Furthermore, individuals with CF possessing a higher _VO2max are shown to have a
reduced mortality risk, as Nixon et al. [8] reported that adults with a _VO2max greater than 82%
of their predicted value had an 83% 8-year survival rate, compared to just 28% 8-year survival
rate for patients with a _VO2max less than 58% of their predicted value [8]. This enhanced sur-
vival has also been reported in a paediatric cohort, with a 100% survival rate after 7 years in
children with CF with a _VO2peak over 45 ml
.kg-1.min-1 [9].
Given the importance of identifying and monitoring aerobic fitness, cardiopulmonary exer-
cise testing (CPET) is recommended to take place on at least an annual basis [10], to provide a
clinically useful prognostic evaluation of a patient’s functional capabilities. Even in mild to
moderate severity of CF, patients are known to demonstrate impairments in cardiac and respi-
ratory functions leading to exercise intolerance which are responsive to exercise training, and
can result in an enhanced quality of life, increased physical function and increased life expec-
tancy [11, 12].
Effective management of the disease is of critical importance due to an aging CF population
group (median predicted survival of children born with CF in the UK is currently 45 years [1])
and high medical care costs [13]. Exercise is widely acknowledged as a key management strat-
egy for CF, supported by mechanistic data on the systemic effects of exercise at the cellular
level in vivo in young patients with CF [6–8, 11, 14]. However, an integrated systems level
understanding of the limitations of aerobic fitness for CF patients is lacking. Measurement
techniques that do exist to quantify within-organ, real-time perfusion and intracellular oxy-
genation are invasive and unethical for use with paediatric patients, and current animal model
research provides limited direct relevance to paediatric pathology. In clinical practice, there is
significant interaction between cardiac, pulmonary and musculoskeletal function, which can
result in the functional improvement in one part of the combined system, but detrimental
effects on others [11]. Clinicians therefore inevitably have to adopt very imprecise guidelines
related to exercise prescription [15].
The use of modelling and simulation tools in clinical medicine is currently the subject of
intense research interest both in the UK and internationally [16–20], and the adoption of a sys-
tems biomedicine approach to build and validate novel multi-scale, organ-level, integrated, re-
usable and re-deployable models represents a paradigm shift in biomedical modelling and sim-
ulation. There are numerous organ level models in existence [21–24], however, to date there
have been limited attempts to either integrate these or to apply them to real clinical applica-
tions. There is ongoing basic science and clinical trial work providing data on the micro [25]
and macrovascular [26] changes associated with exercise. These data, although important,
have yet to be integrated quantitatively with other data streams. In particular, there has been
no previous work on the use of predictive modelling and simulation technologies for develop-
ing treatment strategies for CF patients.
Therefore the aim of this study is twofold. Firstly, to analyse the physiological responses
to progressive exercise in patients with CF, with a view of determining predictors of perfor-
mance. Secondly, to develop a surrogate (statistical) model that allows the evaluation of how
CF impairs exercise tolerance relative to increasing ventilatory and metabolic demands.
Cardiopulmonary modelling in cystic fibrosis
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Specifically, how various ventilatory parameters quantitatively affect the gas exchange thresh-
old (GET) for a group of patients is explored.
Materials and methods
This study was a retrospective analysis of existing CPET data from 15 children and adolescents
with CF. Original ethics approvals was approved by South West NHS Research Ethics Com-
mittees [10/H0107/78; 13/SW/0166; 14/SW/0061] and written informed consent and assent
was obtained from parent(s)/guardian(s) and participants, respectively in accordance with the
Declaration of Helsinki.
CPET data
As part of original studies, all participants performed a valid [27] and reliable [28] combined
ramp incremental and supramaximal (Smax) CPET to determine _VO2max and the GET. This
protocol was performed on an electronically braked cycle ergometer, and required patients to
perform an initial exhaustive ramp incremental test at a pre-determined rate between 10–25
W�min-1, in order to elicit exhaustion in approximately ten minutes [29]. After a 3-min warm-
up at 10–20 W, participants completed this incremental test to the point of volitional exhaus-
tion, maintaining a cadence of 70–80 rpm throughout. Exhaustion was defined as a 10 rpm
drop in cadence for five consecutive seconds, despite strong verbal encouragement. Active
(5-min cycling at 20 W) and then passive seated recovery (10 min) then preceded the Smax
bout. Smax verification consisted of a 3-min warm-up (10–20 W), followed by a ‘‘step” transi-
tion to a constant work rate corresponding to 110% peak power output [30] obtained during
the ramp incremental phase.. Upon volitional exhaustion (defined previously), a 5-min active
recovery (slow cycling at 20 W) concluded the combined CPET session. _VO2max and the GET
were subsequently identified for all participants using established methods which are validated
for use in CF [31].
Models and simulations
Simulations are widely used in various fields of science and engineering because conducting
physical experiments is too costly, or highly time-consuming, or even impossible in some
cases [32]. In the case of CPET in CF patients, there are also ethical considerations, since the
test adds to the treatment burden many children and adolescents with CF already face.
Often, a primary goal of using model simulations is to perform quantitative studies such as
uncertainty quantification or sensitivity analysis. Such studies are crucially important in bio-
medicine, since there exists significant variation both between and within patient groups.
Through understanding and quantification of the uncertainty within the mathematical mod-
els, outcomes of patient-specific interventions can be better predicted. However, such investi-
gations require a large number of runs that makes it impractical if each run takes more than a
few seconds. To cope with this difficulty, one can use emulators, also known as surrogates, or
metamodels or response surfaces [33]. These provide a fast approximation of the input/output
relation governed by the underlying simulator. The most important classes of surrogate mod-
els have been described elsewhere [34–36].
The surrogate model employed in this study is based on Gaussian processes (GPs), which
have become increasingly popular over the last two decades [33]. A Gaussian Process (GP)
defines a probability distribution over functions where the true function is considered as a
particular sample path. GPs have been used in a wide range of applications from wireless com-
munication, to obtain position estimates for a mobile user [37]; metallurgy, to model the
Cardiopulmonary modelling in cystic fibrosis
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development of microstructure [38]; and in biology, to describe gene regulatory processes and
cell growth [39–41]. A GP defines a probability distribution over functions which is fully speci-
fied by its mean, μ, and covariance K [42], which are both functions of the input variables: μ =
μ(x), K = K(x,x’). While μ(x), could be any function (though in practice is often chosen to have
a polynomial dependence on x), the covariance function is required to be positive semi-defi-
nite [42]. Specifically, if Y is a GP defined on the space of input variables denoted by D, then
we write:
Y � GPðm;KÞ : mðxÞ ¼ E½YðxÞ�; Kðx; x0Þ ¼ CovðYðxÞ;Yðx0ÞÞ; 8 x; x0 2 D � Rd
The above can be regarded as “prior” distribution over function spaces. This can be seen
more clearly in Fig 1(a). In this subfigure, which shows a generic example of a GP, the bold red
line is the ‘true’ function f. Note that the true function is unknown—our aim is to construct a
model that approximates it. The thin grey lines are sample functions of a GP distribution
with μ(x) = 0 and a squared-exponential covariance function given by:
K x; x0ð Þ ¼ s2
Yd
i ¼ 1
exp  
jxi   x0ij
2
2F2i
� �
;
Which is a popular choice in GP modelling. Here, σ controls vertical variability of sample
functions and Fi> 0, i = 1, . . ., d, governs the degree of smoothness of them along the input
dimension i. These parameters are usually unknown and estimated via maximum likelihood
method [42]. For exposition purposes, the example plot is restricted to the case d = 1, but the
approach is unchanged for d> 1.
Thus far, we have defined the prior distribution for the GP. It is clear from Fig 1(a) that, in
general, prior distributions are unlikely to provide a good approximation to the true function
f. We can compute the GP “posterior” distribution by incorporating data points (known as
“training data”) obtained from evaluating f at specific points, following a Bayesian framework.
The resulting posterior distribution of the GP, conditioned on the data, will be much closer to
the true function.
Fig 1. GP is a probability distribution over functions. The thick solid red line is the true function f and the thick
dashed black line is the GP “prior”. (a) Thin grey lines show sample functions of the GP. (b) Blue bullets indicate five
data points sampled from f. The GP distribution is updated using these sample data points. The thin grey dashed lines
show m(x) ± 2s(x).
https://doi.org/10.1371/journal.pone.0211219.g001
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Let y = {f(x1), . . ., f(xn)} be a set of function evaluations (or observations) at n locations
X = {x1, . . ., xn}. Here, function evaluations correspond to the GET location for a set of patients
during the CPET. Predicting with GP is obtained by conditioning it Y on sample points the
observations, i.e. O = {X, y} Y(x)|Y(x1) = f(x1),. . .,Y(xn) = f(xn). For any (new) z 2 D, this con-
ditional distribution has a normal distribution with the mean m(z) and variance s2(z) which
are used as the prediction and the associated uncertainty at z posterior, respectively. They are
expressed by distribution of Y(z)|O has a normal distribution with the following mean, m, and
variance, s2:
mðzÞ ¼ mðzÞ þ Kðz;XÞTKðX;XÞ  1ðy   μÞ ð1Þ
s2ðzÞ ¼ Kðz; zÞ   Kðz;XÞTKðX;XÞ  1Kðz;XÞ ð2Þ
where T denotes the transpose operator, -1 is the inverse operator and μ = μ(X) is the vector of
the mean function at X. In addition, K(z,X) and K(X,X) are the covariance vector between Y
(X) and Y(z) and the covariance matrix between the observations. Fig 1(b) shows an example
of incorporating sample points to update the prior distribution shown in Fig 1(a). In this
generic example, the function f is evaluated at five distinct values of x, and the mean and vari-
ance of the GP are updated using (1)-(2).
At the evaluated points, indicated in blue (colour online), the true value of f is known and
so the variance of the GP at these points vanishes and m(x) = f(x). In between these points, the
variance increases, dependent on the distance (in terms of x) from a sampled point. The mean
of the GP, shown by the thick black dashed line now approximates the true function much
more closely (recall that the prior mean function in Fig 1(a) was zero everywhere), and
matches exactly at the evaluated points. The approximation can be further improved by incor-
porating more data points (function evaluations), particularly around those input values for
which the prediction variance s2(x) is high.
The data analysis was performed using Python (Anaconda Software Distribution. Version
2–2.4.0. Continuum Analytics, 2016. URL https://continuum.io) and MATLAB and Statistics
Toolbox Release 2016b, The MathWorks, Inc., Natick, Massachusetts, United States. The GP
model simulator was implemented in R (R Core Team (2013). R: A language and environment
for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL
http://www.R-project.org/.)
Results
Data analysis
To facilitate understanding, we first plot in Fig 2(a), raw data displaying the performance of
the participants. The work rate for each participant is increased at a rate that is either, a)
dependent on their performance in previous tests, or b) when a prior test is unavailable, at a
rate that is predicted to elicit exhaustion in approximately ten minutes [29]. This is done in
order to keep the expected duration of the test comparable to other participants. Note that this
means that the total energy expended by a given participant is not based on the duration of
the test alone. In Fig 2(b), we show how participant age affects overall test performance. We
observe a correlation between the two: the worst performing participants tend to be the youn-
gest, but this effect is insignificant at older ages. The colour coordination used in this figure
(red-worst performance! blue-average performance!green-best performance) will be used
throughout the remainder of this section, where performance is quantified by the total energy
transferred during the test.
Cardiopulmonary modelling in cystic fibrosis
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In Fig 3, we plot the ratio of _VO2 over total ventilation ð _VEÞ with respect to time. The mark-
ers on each of the time traces indicate the time of volitional exhaustion for that participant.
There are two features that stand out from this figure. Firstly, participants who perform better
have higher _VO2= _VE ratios, suggesting that their oxygen uptake is more efficient than their
poorer performing counterparts. Secondly, in the recovery phase of the test (5 minutes follow-
ing volitional exhaustion) better performing participants exhibit a sharp decrease in _VO2= _VE,
which is not observed in the poor performance group. Again, this suggests a more efficient uti-
lisation amongst the former group and that exhalation of CO2 is perhaps more significant to
total breathing following the test.
We next examine the effect that breathing patterns have on participant performance. Two
classical prognostic measures used for patients with cystic fibrosis are the forced vital capacity
(FVC), and the forced expiratory volume in one second (FEV1). These measures have been
shown to be well correlated with mortality and overall fitness of CF patient groups [43–45]. In
Fig 4, we demonstrate how these metrics are correlated with performance in the CPET test. In
Fig 2. (a) The work rate for each participant is increased at a rate dependent on their past test performance. (b) Participant age is correlated
with test performance for young participants, but not for older ones.
https://doi.org/10.1371/journal.pone.0211219.g002
Fig 3. Ratio of oxygen utilisation and total breathing throughout the test. Markers indicate the volitional
exhaustion times for each participant.
https://doi.org/10.1371/journal.pone.0211219.g003
Cardiopulmonary modelling in cystic fibrosis
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Fig 4(a), we observe good correlation between FVC and the maximum tidal volume (VT) of
breathing achieved throughout the test. This is unsurprising since participants are likely to be
trying to maximise their breathing depth close to their exhaustion point. However, notice that,
although the group with low FVC performed poorly, this measure was unable to separate
other participants. Fig 4(b) reiterates this result and also highlights the high correlation
between FEV1 and FVC.
In order to better classify the performance of the participants, we must instead look for
other factors. In Fig 5, we present the total breathing rate against the oxygen consumption
throughout the test. In Fig 5(a), we find a strong relationship between test performance and
respiratory pattern. Note that the curvature of the graphs suggests that an exponential fit,
rather than a linear one, is most appropriate for these data. In order to test this, we take loga-
rithms of the data and perform a linear regression, ignoring the first 180s of the test since par-
ticipants are here in the warm up phase (work rate is not increasing) and the final 60s of the
data prior to volitional exhaustion, since participants pass their respiratory compensation
point, inducing hyperventilation and erratic breathing. The results of the fit are shown in
Fig 5(b), where we can clearly see the dependence of performance on breathing pattern.
Fig 4. (a) Correlation of FEV1 with the maximal tidal volume achieved throughout the test. (b) Correlation between FEV1 and FVC
is high. Note that, although FVC and FEV1 are good predictors of poor test performance, they are unable to distinguish better
performing participants.
https://doi.org/10.1371/journal.pone.0211219.g004
Fig 5. (a) Total ventilation plotted against oxygen utilisation. We observe that breathing pattern is strongly correlated with test
performance. (b) Exponential curves are fitted through the raw data, further highlighting this dependence.
https://doi.org/10.1371/journal.pone.0211219.g005
Cardiopulmonary modelling in cystic fibrosis
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From the fitted curves, we can further explore the dependence of breathing patterns on per-
formance. Firstly, in Fig 6(a), we depict the slope of the fitted curve against the total energy
transfer. We find that the slope of the curve of log _VE against _VO2 alone does not capture all of
the variation in energy, which is highlighted by the relatively low coefficient of determination
(0.68). Instead, we plot in Fig 6(b) the oxygen consumption at a fixed rate of breathing against
the total energy. Here, we find a very good characterisation of the overall performance, with a
much higher coefficient of determination (0.86), confirming that those who utilise oxygen
more efficiently perform better.
Next, we examine the specific patterns of breathing exhibited by the participants, in particu-
lar, focussing on breathing depth and frequency. Initial characterisations of these patterns
seem to provide little information, as indicated in Fig 7(a). However, when we now also
include dependence of oxygen consumption, we find a near perfect classification of partici-
pants into the lowest performing groups, the best performing groups and the middle group.
These data are shown in Fig 7(b). Note that in this figure, the trajectories appear to be evolving
on a planar manifold, suggesting significant co-dependence between these three variables.
Given that there appears to be co-dependence between the variables used in Fig 7(b), a nat-
ural next step is to use principal component analysis (PCA) to account for these dependencies.
By projecting the data onto their principal components, we show in Fig 8 how well these
Fig 6. Slope of the fitted curves (log _VE against _VO2) from Fig 4(b) plotted against the total energy transfer during the test. We
find a relatively poor characterisation of the variance between performances. (b) By instead plotting the oxygen consumption at a
fixed rate of breathing, we better capture differences in performance.
https://doi.org/10.1371/journal.pone.0211219.g006
Fig 7. (a) Breathing patterns subdivided into the breathing rate and tidal volume. These data appear uninformative for
predicting test performance. (b) With the additional inclusion of the oxygen consumption at a fixed rate of breathing,
we find that these variables now almost perfectly capture variation in participant performance.
https://doi.org/10.1371/journal.pone.0211219.g007
Cardiopulmonary modelling in cystic fibrosis
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components capture the variation in participant performance. Given that there are only three
independent variables in our analysis, it is convenient to use spherical polar coordinates to
show how these quantify performance. The first of these components, θ, captures over 90% of
the variation in performance (Fig 8a), as does the normal component in the direction of
breathing frequency (Fig 8b). These results further indicate the importance of breathing fre-
quency, together with co-variation of oxygen consumption and tidal volume as predictors of
test performance.
Gas exchange threshold
Under steady state levels of exercise, the metabolic rate of production of CO2 is assumed to be
proportional to the utilisation rate of O2 via the cellular respiratory quotient, since (after the
initial rest-work transition) adenosine triphosphate (ATP) is replenished primarily via aerobic
metabolism pathways. As the work rate increases, this pathway becomes unable to supply suffi-
cient ATP to satisfy the required amount of energy and anaerobic pathways have to contribute
to overcome the shortfall. In so doing, they increase the levels of metabolic waste products,
such as lactate and also increase the overall production rate in CO2. The point at which this
occurs is known as the anaerobic threshold (AT) or sometimes can be referred to as the lactate
threshold. The lactate threshold can be estimated non-invasively by the determination of the
GET [46]. Within this study, the GET was successfully identified in all CPETs.
Anaerobic thresholds are well correlated with overall performance, as shown in Fig 9(a),
due to the fact that the anaerobic pathways are less efficient at producing ATP and because
build-up of lactate contributes significantly to fatigue. One of the major contributing factors in
defining GET is _VO2max, since this is indicative of the limit of the rate of oxidative phosphory-
lation. It thus comes as little surprise that _VO2max is the best single predictor of CPET perfor-
mance, as shown in Fig 9(b).
Gaussian processes-based modelling
Having completed a detailed data analysis and identified candidate predictors of CPET perfor-
mance we next use these predictors to inform a Gaussian Process-based model. In our model-
ling, we attempt to describe the influence of breathing patterns and _VO2 on the GET, since
this is shown to correlate well with overall test performance (see Fig 9). In mathematical terms,
we treat GET as our scalar output variable, with input variables comprising: baseline breathing
Fig 8. The first principal component obtained via PCA accounts for over 90% of the variation in test performance. (b) Similar
levels of variance are accounted for by taking only the normal component of the first principal component, θ, in the breathing
frequency direction.
https://doi.org/10.1371/journal.pone.0211219.g008
Cardiopulmonary modelling in cystic fibrosis
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rate and tidal volumes, and O2 consumption rates at a fixed ventilation rate, FVC, FEV1, and
the rate of changes in breathing rate and tidal at exercise onset, using the slopes calculated
based on the analysis presented in Fig 5(b). Thus, we have an output variable that dependents
on seven input variables, which we store in a vector x 2 D � Rd, with d = 7. We now assume
that there exists a ‘true’ function f: D! R, such that GET = f(x).
GP emulator performance
The GP emulator was constructed using the data presented above, with GET calculated using
previously described methods [46]. These data were used to train the emulator. We consider a
first order polynomial regression for the mean μ(.) and the squared-exponential covariance
function for K(.,.). Since in this pilot study, we have a small number of participants, we use
leave-one-out cross-validation mean squared error (MSELOO) to assess the accuracy of our
emulator. It is defined as
MSELOO ¼
1
n
Xn
i ¼ 1
ðm  iðx
iÞ   f ðxiÞÞ2;
where m−i(xi) is the prediction obtained by the GP model based on all the training data points
except the i’th one [47]. The corresponding prediction uncertainty is denoted by s2
  1
ðxiÞ. In
this work, MSELOO = 0.1676 which is around 12% of the global mean for GET. Fig 10
shows exact values (bullets) vs. m−i(xi) (asterisks) with the 95% confidence intervals, i.e.
m  iðxiÞ � 1:96s  iðxiÞ; for each patient, we use the emulator trained against the remainder of
the training data to approximate the AT value for that patient, given their input variables.
The emulator has reasonable accuracy, in spite of the small number of data used to train it.
In general, for high accuracy in GP emulator, the number of sample training data (correspond-
ing to the number of patients in our case) should be around ten times larger than the number
of input variables [48]. Clearly, there is a need to acquire further data points to improve the
predictive capabilities of the emulator. For each patient, the 95% confidence interval around
the predicted point contains the true value. However, the large variance in the GP estimates
for some patients (e.g. patient 8) highlights a need to extend this study to include more data to
refine estimates around these points, particularly to deal with the high variability of lung func-
tion parameters in this patient group [49].
Fig 9. (a) Quantifying the relationship between the anaerobic threshold and overall test performance. Thresholds were
calculated using an automated procedure based on previous methods [46] (b) _VO2max is the best single predictor of
overall test performance.
https://doi.org/10.1371/journal.pone.0211219.g009
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Combining patients’ data with mechanistic modelling
An alternative to the Gaussian Process-based modelling approach above would be to directly
use the experimental data in a mechanistic modelling framework. Next we present an example
of employing this alternative approach. During exercise, it is known that dead-space ventila-
tion rate, _VD increases [50]. Thin et al [50], demonstrated that this increase is significantly
greater in CF patients. Physiologically this is because, in CF patients, tidal volume, VT is lim-
ited. Therefore, there must be an increase in the frequency of breathing, BF, in order to main-
tain gas exchange.
Fig 11(a) shows the changes in these ventilatory parameters at rest and during peak exercise
for the 15 CF patients. This figure indicates that tidal volume is decreased in the CF patients as
the disease severity increases. Thus, it seems reasonable to suggest that the size of increase in
_VD with exercise is dependent on the severity of the disease. We can now consider this in the
case of the 15 CF patients tested. For each of these patients a work rate was prescribed depen-
dent on their previous performances (see Fig 2). We incorporate the work rate data in the
mechanistic model by Timischl [51] in order to predict _VE for each individual patient (see S1
File for details on the mechanistic model). It is important to note that Timischl’s original
model ignores the dead-space (i.e. assumes _VD = 0). Figure A in S1 File shows that generally
for CF patients whose disease is less severe (those in green) _VE is captured better with no venti-
latory dead-space than those whose disease is more severe. We therefore suggest incorporating
the dead space by modelling _VD using a linear function of the form, _VD = _VDB + a × W(t),
where _VDB is the base level of _VD for each patient, a is a scaling parameter based on the severity
of the disease and W(t) is the work rate. We anticipate that for those patients whose disease
progression is less severe a relatively low scaling factor will be needed and for those whose con-
dition is more severe, a much larger one. To determine the values of _VDB and a we use the
available experimental data. It is known that, _VD = BF × VD. As shown in Fig 11(a) the avail-
able data allows us to obtain values for BF and VD both at rest and during exercise. We can
therefore determine a value for _VDB as follows, _VDB = BF (Rest) × VD (Rest), and a value for a
Fig 10. Predictions (asterisks) vs. exact values (bullets). Red bars show the 95% confidence intervals, mi(xi) ± 1.96 si(xi) around the
predicted value, where mi and si are GP prediction mean and standard deviation based on all but the i’th data point.
https://doi.org/10.1371/journal.pone.0211219.g010
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as follows, a = (BF (Exercise) × VD (Exercise)) / W (Exercise). Next, we simulate the model
with this added ventilatory dead-space (model predictions are shown in Figure B in S1 File).
This allows us to obtain predictions for the total ventilation ( _VE) for each individual patient as
shown in Figure B in S1 File. The results from these simulations in turn allow us to predict
alveolar ventilation, _VA, for each patient as shown in Fig 11(b). In Fig 11(b) we plot _VE from
the data, along with the predicted by the modified model simulations values for _VD. Then
using _VA = _VE − _VD to find _VA, we can predict the changes in _VA during exercise for the 15
CF patients.
This is an example of how individual patient’s data could be used in a mechanistic model
framework in order to predict individual patients’ characteristics, in this case associated with
ventilatory parameters and hence lung function.
Discussion
Our primary long-term modelling aim is to eventually use the models to evaluate how CF
impairs exercise tolerance relative to increasing ventilatory and metabolic demands. Our pre-
dictive models could also be used to evaluate therapies and their effect on exercise perfor-
mance. Ultimately, we hope that this will form a series of steps to design better exercise
treatment that is tailored to specific individual needs relative to patient’s treatment therapies, a
treatment modality that is affordable, and personalised [52]. It is interesting to note that in
spite of the small number of data points used to train our GP emulator, the accuracy as com-
puted by the leave-one-out cross-validation mean square error is high. This observation
implies that the relationship between GET and our chosen input variables is ‘smooth’ (in that
there are no large, sudden changes in GET as our input variables vary) [53]. In turn, this pro-
vides further evidence that our chosen input variables are good predictors of GET for this
patient group.
Fig 11. (a) Tidal volume (VT), an estimate for the dead volume (VD) and Breathing frequency BF from the data.
(b) Changes in ventilatory parameters during exercise for the 15 CF patients using the proposed form of
_VD = _VDB + a × W(t). In the case of _VE the solid dots represent values extracted from the data, for _VD and _VA these
represent values taken from model simulations (see S1 File). In all cases the red stars represent the group mean.
https://doi.org/10.1371/journal.pone.0211219.g011
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The data analysis and modelling results have highlighted the dependence of CPET perfor-
mance on variables associated with ventilation and metabolic rates of O2 consumption. We
believe that this is the first attempt to mathematically model the relationship between ventila-
tory dynamics, _VO2 and performance in CPET within a group of children and adolescents
with CF. Whilst it is clear that there is much work to be done in this area, we hope that this
will serve as a starting point for improved modelling for CF, not only in the arena of GP emu-
lators, but also in the domain of mechanistic modelling, which we shall describe briefly. But
one of the benefits of modelling includes the ability to utilise existing data sets at a time when
there are limited resources and time for a patient group who can be very sick and unable to
engage in research.
Perspectives for GP improvements
In our simulator, we have used the GET as our output (dependent) variable. Another choice
for this could be the performance in the CPET or _VO2max, since these are the primary biomark-
ers for gauging aerobic fitness. However, the use of the GET has been shown to have high
agreement with the lactate threshold (another surrogate for the AT), and related to disease
severity in CF [54]. Furthermore, as reported in Fig 9(a), the GET location for a given patient
correlates well with their overall performance in this test. Importantly, by constructing a pre-
dictive model to approximate the GET values for a patient, we can hope to further extend this
to identify contributions of aerobic and anaerobic pathways in supplying ATP to meet the
demand imposed during the exercise test.
The initial exploration of results highlighted that both ventilation parameters and metabolic
rates of O2 consumption were the primary factors influencing test performance. It is clear that
_VO2 should play a significant role in determining the GET location, since it is a proxy for oxi-
dative phosphorylation which is the main pathway for ATP synthesis in steady state exercise.
As a measure of oxygen uptake efficiency in our model, we use the oxygen consumption rate
at a fixed total ventilation rate (that being 0.822 L�s-1) as an input (independent) variable for
each patient.
There are a number of ventilatory input variables incorporated in our simulator. Given
their potential importance as clinical biomarkers, highlighting the limitations of lung capacity
and function, we include FVC and FEV1 as input (independent) variables. During the aerobic
exercise test, participants spend three minutes cycling at a minimal work rate, over which we
quantify their baseline breathing frequency and baseline tidal volume by taking the means of
these variables over this period. To capture the dynamics response associated with the exercise,
the rates of change of breathing frequency and tidal volume are calculated, based on the fits
obtained in Fig 5(b). The rates of change of these ventilatory variables indicate how individual
participants respond to changes in work rate and were shown in Fig 7(b) to discriminate
between participant performances. Moreover, differences in rates of change of breathing fre-
quency and tidal volume have previously been shown to be significantly different between con-
trol groups and CF groups [50], suggesting that these are potentially key biomarkers for
assessing aerobic fitness in patients with CF.
At present, the GP model is conditioned on specific data points for each patient. An
improvement to the GP could be made by instead conditioning with respect to distributions.
Given that repeated tests are often performed for the same individual, so that multiple sample
points are provided for each participant, we can consider a fit to a probability distribution cap-
turing the variability in the identified variables. This approach has advantages compared to
standard GP models, such as avoiding problems associated with over fitting and regularisation
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(which is important for the inverting ill-conditioned covariance matrices that often arise dur-
ing the application of [1, 2, 55]).
Perspectives for mechanistic modelling
In order to better understand and characterise the difference between performances, it would
be extremely informative to construct and simulate a mechanistic mathematical model, based
upon on an ordinary differential equation (ODE) framework, describing the relationship
between the cardiopulmonary system and the metabolic dynamics of skeletal muscle. By
describing the relationships between different organ-level systems, the model would be able to
identify the patient-specific rate-limiting factors defining aerobic fitness. Moreover, analysis of
the model could be used to suggest treatment strategies to improve these factors and thus pre-
dict how patients will improve under such regimes.
At the individual organ level, there are a plethora of models describing individual dynamics
of the level of the heart [56–59], lung [60–63] and systemic metabolic demand [64–70]. There
also exist a number of models describing such interactions between cardiopulmonary and
metabolic systems [51, 71–74] in a variety of settings, including heart failure and mechanical
ventilation. A core feature in all of these models is the nonlinear interactions between the con-
stituent model compartments that encompass the distinct tissues. An important consequence
of this is that the model must be studied as whole, in an integrated fashion, to truly understand
the body’s response to exercise.
With respect to the present question, there are a number of limitations of the existing
modelling approaches. Most significantly, none have been designed with either an adolescent,
or a CF patient group in mind, and the nuances of these patient groups will have to be factored
into to any model development. In particular, these models have relatively simple, empirical
models to describe changes in ventilation, which may not capture well the breathing dynamics
of our patient group. Moreover, to the best of our knowledge, no model considers the changes
in ventilation separated into breathing frequency and depth that have been shown by us and
others [50] to be critical to overall test performance.
In our analysis, we have demonstrated that the GET location is a critical factor in determin-
ing overall patient aerobic fitness. Many of the mathematical exercise models describe only
steady-state exercise, in which aerobic pathways meet most of the ATP demand [51, 71–74].
As such, these models are inadequate to capture the dynamics we describe here. Another com-
mon topic of study is the dynamic response at exercise onset, which again, does not meet the
current need to describe the GET crossing point [75–78].
Of the mathematical models that describe the contribution of anaerobic pathways to ATP
production, some assume that the shortfall in meeting ATP demand via oxidative phosphory-
lation is met entirely by anaerobic pathways [79], yet this is clearly not so, since ATP levels
in skeletal muscle post-exercise may be up to 30% lower than pre-exercise values [80]. Mathe-
matical models that factor in fatigue brought about by anaerobic metabolism are generally
phenomenological in nature, and it is difficult to quantify these models against real patient
data [79, 81, 82]. Moreover, these models mostly fall outside the arena of ODE-based model-
ling and so dynamical properties are difficult to infer from them.
Developing a mathematical model to describe the integrated behaviour of all of the relevant
organs, whilst remaining biophysically plausible, but without requiring excessive or invasive
parameterisation, is a difficult task. The proposed model should include descriptions of the
cardiovascular system, the ventilatory system and simple models of metabolism at the tissue
level. Specifically, dynamic variables should include alveolar, arterial, venous and tissue level
partial pressures/concentrations of O2 and CO2, cardiac output, ventilation and metabolic
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rates oxygen utilisation and CO2 production. Partial alveolar gas pressures can be linked to
data collected during the test, and the work rate can then be provided as inputs to the model.
Note that these variables are similar to those included in previously defined models [51, 71–
74] and the aim is to extend these to describe the dynamics observed in patients with CF. The
proposed model schematic is displayed in Fig 12.
Of critical importance to the overall model construction is the development of a simple, yet
realistic model of cellular metabolism, to overcome the issues discussed earlier. The model
should respect the different metabolic processes that occur in the muscle tissue, in particular:
glycolysis, phosphocreatine breakdown and synthesis and oxidative phosphorylation, in a sim-
plistic fashion that is amenable to being fit to CPET data. Whilst there are models that describe
the biochemical reactions associated with these processes, and importantly, their stoichiometry
[65, 68, 70, 73, 83], quantifying their associated rate constants in vivo is a near-impossible task,
and so efforts must be made to develop a model that incorporates the relevant metabolic
dynamics whilst being simple enough to be fit to data.
With knowledge of the integrated system, attempts can also be made to describe other
important exercise-based processes, such as lactate buffering and recycling (as a fuel source)
[68, 84, 85] and the overall muscle fatigue brought about by the combination of all of these
factors. Only by systematically exploring the dependence of aerobic fitness of all of the fac-
tors described in this section can we begin to understand the system in an integrated
fashion.
Fig 12. Schematic of the variables and processes in the proposed ODE-based mathematical model. Adapted from
Timischl [51] and Batzel et al. [86].
https://doi.org/10.1371/journal.pone.0211219.g012
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Limitations
A limitation with the current study is the utilisation of a relatively small sample size, and this is
most likely contributing towards aforementioned errors in prediction. Future studies should
seek to utilise CPET collected annually in CF centres, to develop larger, multi-centre, samples
whereby a uniform exercise protocol is utilised. Given that utilisation of CPET is now recom-
mended and endorsed for regular use by international medical societies [87], and individual
CF centres are reporting upon experiences of using CPET [88], large-scale utilisation of such
data is a feasible target.
The findings presented here are derived from a smaller sample, and therefore the models
presented are only preliminary models of this patient cohort; however, our study provides a
unique examination into the aerobic and anaerobic signatures of individual patients with CF
in response to progressive exercise.
As models improve, as well as the quality of fits to data (through increased sample sizes),
these can be used in a prognostic setting to predict potential improvements in aerobic fitness
that may arise due to therapeutic intervention. Moreover, with proper mechanistic modelling
of the primary organs affected in CF, there exists the potential to optimise treatment for this
patient group by identifying the limiting factors of aerobic fitness. Finally, whilst this study
provides an insight into metabolic process during exercise, future research and models must
account for additional variables predictive of function and mortality (e.g. genotype, body com-
position, pancreatic sufficiency, infection status, exacerbations [89, 90]) and co-morbidities
(CF-related diabetes [91], pulmonary arterial hypertension [92]) existent within CF, notably
those that may affect exercise tolerance.
Conclusions
In conclusion, our proposed stimulator allows for the reproduction of the physiological obser-
vations of ventilation and metabolic rates of O2 consumption acquired during a CPET in
relation to people with CF. The modelling framework was able to successfully replicate the
relationship between ventilatory dynamics, lung capacity and function and performance in
CPET within a group of children and adolescents with CF. In particular, by using the Gaussian
processes (GP) the GET, a well-known physiological threshold marker of exercise intensity, as
well as other important measurements such as breathing frequency and tidal volume, at the
individual patient level were accommodated into the model. The stimulator has the potential
to be suitable for future applications of the investigations of drug therapies or other physical
interventions on exercise performance.
Supporting information
S1 File. Cardiopulmonary responses to maximal aerobic exercise in patients with cystic
fibrosis. Figure A: Model simulations of _VE assuming VD = 0, compared to the recorded data
value of _VE obtained during the CPET. The thin red line gives _VE as measured from the data
and the bold coloured line gives _VE as simulated by the model. The colour given to each
patient is the same as given in Fig 2 in the main text of the paper. Figure B: Model simulations
of _VE using the proposed linear model of VD, compared to the recorded data value of _VE
obtained during the CPET. The thin red line gives _VE as measured from the data and the bold
coloured line gives _VE as simulated by the model. The colour given to each patient is the same
as given in in Fig 2 in the main text of the paper. Fitted parameter values can be found below.
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Table A: Parameter values. Table B: Calculated values of _VDB and a for the linear model of
ventilatory dead-space. Table C: Definitions of model parameters.
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